Crescendo Equity Partners

Crescendo Equity Partners is a private equity firm headquartered in Seoul, South Korea, specializing in mid-market growth capital investments across technology, manufacturing, and healthcare. Founded in 2012 with significant sponsorship from PayPal co-founder Peter Thiel, the firm has emerged as a key player in the life sciences sector through its strategic acquisition of Medipost, a leading developer of stem cell therapies. Crescendo focuses on identifying companies with strong intellectual property and providing the operational expertise necessary to scale them into global leaders. Their healthcare portfolio is anchored by the development of mesenchymal stem cell-based treatments, such as Cartistem, which is currently undergoing global clinical trials for knee cartilage defects. The firm actively manages its investments through restructuring and global expansion initiatives, aiming to drive long-term value in the biotechnology and high-tech industries.